288-OR: Effect of 24 Months of Optimised Glucose Control on Residual C-Peptide Secretion in Youth with New Onset Type 1 Diabetes (T1D)

288-OR: Effect of 24 Months of Optimised Glucose Control on Residual C-Peptide Secretion in Youth with New Onset Type 1 Diabetes (T1D)

Background: We assessed whether improved glucose control with hybrid closed loop can preserve C-peptide secretion compared to standard insulin therapy in youth with T1D. Methods: In a multicentre, randomised, parallel trial, youth aged to

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes (New York, N.Y.) N.Y.), 2022-06, Vol.71 (Supplement_1)
Hauptverfasser: BOUGHTON, CHARLOTTE K., WARE, JULIA, ALLEN, JANET M., WILINSKA, MALGORZATA E., HARTNELL, SARA, THANKAMONY, AJAY, RANDELL, TABITHA, GHATAK, ATRAYEE, BESSER, RACHEL, ELLERI, DANIELA, TREVELYAN, NICOLA, CAMPBELL, FIONA, SIBAYAN, JUDY, BAILEY, RYAN, CALHOUN, PETER, DUNSEATH, GARETH J., HOVORKA, ROMAN, CONSORTIUM, CLOUD
Format: Artikel
Sprache:eng
Schlagworte:
Diabetes
Diabetes mellitus (insulin dependent)
Glucose
Hemoglobin
Insulin
Peptides
Secretion
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background: We assessed whether improved glucose control with hybrid closed loop can preserve C-peptide secretion compared to standard insulin therapy in youth with T1D. Methods: In a multicentre, randomised, parallel trial, youth aged to
ISSN:0012-1797
1939-327X
DOI:10.2337/db22-288-OR